The Nasdaq Biotechnology Index: Longer-Term Technicals Are Beginning to Look Attractive

After approximately two years of underperformance relative to the S&P 500 Index, the NASDAQ Biotechnology Total Return Index’s (XNBI) longer-term technical indicators are once again beginning to look attractive. On June 20, 2017, the XNBI’s monthly relative strength price chart … Continue reading →